Placeholder

Ibrutinib Manufacturer

Active IngredientIbrutinib
Dosage FormCapsules
Available Strength140mg
Packaging30 capsules in 1 bottle
Therapeutic useMantle-cell lymphoma, Blood cancer (Chronic lymphocytic leukemia)
Pack Insert/LeafletYes
Production Capacity1 Million Bottle's/Month

Description